BlackRock Amends Adicet Bio Stake, Signals Ownership Change
Ticker: ACET · Form: SC 13G/A · Filed: Feb 7, 2024 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | SC 13G/A |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock updated its Adicet Bio stake, signaling a change in its position.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 7, 2024, disclosing its ownership in Adicet Bio, Inc. as of January 31, 2024. This amendment (Amendment No. 2) indicates a change in BlackRock's beneficial ownership of Adicet Bio's Common Stock. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in its confidence in Adicet Bio's future prospects, potentially influencing other investors' decisions.
Why It Matters
Changes in large institutional holdings like BlackRock's can influence stock price and investor sentiment, as they often reflect deep analysis of a company's fundamentals and future outlook.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a direct risk to the company or its investors.
Analyst Insight
An investor should monitor subsequent filings from BlackRock or other major institutions to understand the direction and magnitude of their ownership changes in Adicet Bio, as this could indicate a broader institutional trend.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Adicet Bio, Inc. (company) — the subject company whose securities are being reported
- January 31, 2024 (date) — the date of the event requiring the filing
- February 7, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment (Amendment No: 2) to a Schedule 13G filing under the Securities Exchange Act of 1934.
Which entity filed this SC 13G/A?
BlackRock Inc. filed this SC 13G/A, as indicated in the 'FILED BY' section of the filing.
What is the subject company of this filing?
The subject company is Adicet Bio, Inc., as stated under 'SUBJECT COMPANY: COMPANY DATA'.
What is the CUSIP number for the securities reported?
The CUSIP number for the Common Stock of Adicet Bio, Inc. is 007002108, as listed in the filing.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required the filing of this statement was January 31, 2024.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 7, 2024 regarding Adicet Bio, Inc. (ACET).